Also, in inflammatory diseases such as rheumatic disorders some lesions could respond to anti-tumor necrosis factor (TNF) and others to anti-CD20 because the different lesions are asynchronous and with different histology even in the same patient. This evidence concerns the gene TNF and rheumatic disorder.